Hospital de Santa Maria
Lisbon, Portugal
NCT Number: NCT01907698
Vaginal intercourse to promote labour onset is biologically plausible. Oxytocin release during female orgasm, cervix mechanical stimulation and the effect of semen's prostaglandins are possible involved mechanisms. The investigators propose to evaluate the effect of vaginal intercourse on spontaneous labour at term.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Lisbon, Portugal
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
vaginal intercourse at least twice a week
Time frame: Spontaneous labour onset between 37 and 42 weeks of pregnancy
Spontaneous labour was considered to be established when there were regular contractions and at least 3cm of cervical dilation.
Time frame: Gestational age at delivery (between 37 and 42 weeks of pregnancy)
Time frame: Mode of delivery (vaginal or cesarean delivery) up to 42 weeks of pregnancy
Route of delivery - vaginally or cesarean
Time frame: number of days between patients study recruitment and delivery (maximum period of 28 days - between 38 and 41/0-6 weeks/days of pregnancy)
number of days between patients study recruitment and delivery (patients were included in the study at 38 weeks of pregnancy and followed until delivery; if spontaneous labour did not occur labour induction was scheduled during the 41th week of pregnancy)
Hospital de Santa Maria, Portugal
Other
Effect of Vaginal Intercourse on Spontaneous Labour at Term- A Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05664802
Acquired Immunodeficiency Syndrome, Behavior
Flagstaff, Arizona, United States
View Trial DetailsNCT05120869
Behavior, COVID-19
Las Cruces, New Mexico, United States
View Trial DetailsNCT06098690
Adherence, Patient, Behavior
El Paso, Texas, United States
View Trial DetailsNCT05242952
Behavior, Blood-Borne Infections
Orange, Connecticut, United States
View Trial Details